The burgeoning popularity of retatrutide, initially for metabolic conditions, is creating significant interest within the UK , prompting a notable shift in medication trends. Obtaining these compounds remains a complex situation , with NHS provision currently limited and independent providers offering prescriptions at a higher cost . Concerns are b